Pet-Specific Care for the Veterinary Team. Группа авторов

2.13 Placebo and Nocebo

       Lowell Ackerman, DVM, DACVD, MBA, MPA, CVA, MRCVS

       Global Consultant, Author, and Lecturer, MA, USA

BASICS

      2.13.1 Summary

      The concept of placebo is well known in human medicine, but it often does not get the same sort of respect when it comes to the use of medications in animals. It might be inferred that pets are the best “blinded” controls when it comes to therapeutics since pets do not know if they are being administered active medications, and yet since it is pet owners that ultimately report on what works and what doesn't, placebo is an important topic in veterinary medicine as well.

      2.13.2 Terms Defined

      Nocebo: A negative type of placebo effect in which being informed that there could be adverse effects associated with a therapy increases the likelihood that adverse effects will be experienced and reported.

      Placebo: The beneficial effect perceived for a product without actual physiological impact.

MAIN CONCEPTS

      The placebo effect is well recognized in human medicine, but it was once believed that animals could not cognitively appreciate that a medication would be of benefit to them and react accordingly. However, there are several reasons why this line of reasoning may not be correct.

      A lot of work has been done on the placebo effect, including the concept of honest placebos (patients or caregivers know something is a placebo but they discern benefit regardless). It's an important concept in veterinary medicine, not because the animals can be fooled but because the owners may identify responses as positive. In our pet‐specific forum, it is important to realize that just because a pet responded, this does not mean that we made the correct diagnosis and selected the appropriate medication in all cases. We also need to account for placebo and nocebo in animals.

      2.13.3 Caregiver Placebo Effect

      While animals may not be able to directly perceive benefits from placebo therapies, the same cannot be said of the caregivers who are administering the medications and/or assessing its effects. This includes veterinarians, who are often eager for their interventions to have documentable success. In fact, the caregiver placebo effect may be evident around 30–40% of the time regarding subjective evaluations, such as for lameness in dogs and cats.

      2.13.4 The Hawthorne Effect

      Another manifestation of caregiver placebo effect can be seen as a feature of being enrolled in a study, or receiving an intervention perceived as new and potentially exciting – known as the Hawthorne effect. With the extra attention potentially shown by veterinary staff, and more scrutiny and monitoring, it is quite possible that pet owners will have expectation‐based placebo effects. Conceivably, they may approach their pet in a more positive manner, spend more time praising and having physical contact with it, and pets can respond to that increased attention.

      If studies in human medicine are any indication, the placebo effect can also be enhanced if clients are told a medication is hard to get or expensive; the color of the tablet can also affect degree of perceived benefit. All of this supports the contention that a placebo is more than just an inert substance without physiological effects, even if those effects cannot be completely explained.

      2.13.5 Regression to the Mean

      When treating chronic problems, such as arthritis, allergies, inflammatory bowel disease, and others, there tends to be a progressive nature to the diseases, but attitudes and clinical signs tend to wax and wane over time – there are good days and bad days.

      When patients are having “bad days” and are clinically at their worst, this is the most likely time when clients are going to be most receptive to trying something new. Since waxing and waning of clinical signs is typical, it is also not unusual that a percentage of patients will be better following the administration of anything – be it a legitimate therapy or a placebo – just because that is the fluctuating nature of chronic disease.

      In other cases, even though chronic problems are by their very definition “chronic,” there can be much larger cycles that can explain observed changes from placebo. For example, with atopic dermatitis, pets may be worst during peak pollination periods for specific allergens. During the worst periods of such pollination, owners are more likely to be desperate for new treatment alternatives. However, intense pollination periods tend to be relatively short‐lived, so in some instances the allergen load may actually have diminished significantly on its own and the clinical benefits should really be attributed to this discontinuation of intense pollination. Just because a pet gets better on a therapy does not mean that the primary effect can be attributed to the medication.

      2.13.6 Honest Placebo

      One very interesting aspect of placebo studies is that sometimes they can still provide benefits even if the patient/client knows they are administering placebos. This is known as the honest placebo effect. Thus, human researchers for several years have been conducting open‐label placebo studies where patients know they are receiving placebo, and still documenting benefit. We know that for some clients, there is an expectation that they will receive at least some sort of medication for whatever problem their pet might have. In fact, even some veterinarians might feel the need to dispense something for a client in need, even if there is not a specific medical indication. For example, sometimes clients request antibiotics for a pet when it is sick, even if there is no indication of bacterial involvement. Sometimes owners

Скачать книгу